SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BPMC, SAGE, SOL on Behalf of Shareholders
Written by Emily J. Thompson, Senior Investment Analyst
Source: PRnewswire
Investigation of Companies: Halper Sadeh LLC is investigating Blueprint Medicines Corporation, Sage Therapeutics, and Emeren Group for potential violations of federal securities laws related to their sales to other companies, with offers including cash payments and contingent value rights for shareholders.
Legal Rights for Shareholders: The law firm encourages shareholders from the involved companies to contact them for free consultations regarding their legal rights and options, emphasizing that they operate on a contingent fee basis.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
